RU2370489C2 - Кристаллическая форма хинолинового соединения и способ получения данного соединения в указанной форме - Google Patents

Кристаллическая форма хинолинового соединения и способ получения данного соединения в указанной форме Download PDF

Info

Publication number
RU2370489C2
RU2370489C2 RU2006127044/04A RU2006127044A RU2370489C2 RU 2370489 C2 RU2370489 C2 RU 2370489C2 RU 2006127044/04 A RU2006127044/04 A RU 2006127044/04A RU 2006127044 A RU2006127044 A RU 2006127044A RU 2370489 C2 RU2370489 C2 RU 2370489C2
Authority
RU
Russia
Prior art keywords
compound
crystal
crystalline form
water
obtaining
Prior art date
Application number
RU2006127044/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2006127044A (ru
Inventor
Йосио ОХАРА (JP)
Йосио ОХАРА
Ясутака ТАКАДА (JP)
Ясутака ТАКАДА
Хироо МАЦУМОТО (JP)
Хироо Мацумото
Акихиро ЙОСИДА (JP)
Акихиро ЙОСИДА
Original Assignee
Ниссан Кемикал Индастриз, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34736450&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2370489(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ниссан Кемикал Индастриз, Лтд. filed Critical Ниссан Кемикал Индастриз, Лтд.
Publication of RU2006127044A publication Critical patent/RU2006127044A/ru
Application granted granted Critical
Publication of RU2370489C2 publication Critical patent/RU2370489C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU2006127044/04A 2003-12-26 2004-12-17 Кристаллическая форма хинолинового соединения и способ получения данного соединения в указанной форме RU2370489C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003-431788 2003-12-26
JP2003431788 2003-12-26

Publications (2)

Publication Number Publication Date
RU2006127044A RU2006127044A (ru) 2008-02-10
RU2370489C2 true RU2370489C2 (ru) 2009-10-20

Family

ID=34736450

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006127044/04A RU2370489C2 (ru) 2003-12-26 2004-12-17 Кристаллическая форма хинолинового соединения и способ получения данного соединения в указанной форме

Country Status (21)

Country Link
US (19) US20070112024A1 (enExample)
EP (1) EP1697326B1 (enExample)
JP (7) JP5186108B2 (enExample)
KR (11) KR20190083674A (enExample)
CN (2) CN1898211A (enExample)
AT (1) ATE518835T1 (enExample)
AU (2) AU2004309241A1 (enExample)
CA (1) CA2551050C (enExample)
CY (1) CY1112464T1 (enExample)
DK (1) DK1697326T3 (enExample)
ES (1) ES2367172T3 (enExample)
IL (1) IL176470A (enExample)
MX (1) MX338019B (enExample)
NZ (1) NZ548041A (enExample)
PL (1) PL1697326T3 (enExample)
PT (1) PT1697326E (enExample)
RU (1) RU2370489C2 (enExample)
SI (1) SI1697326T1 (enExample)
TW (1) TWI328006B (enExample)
WO (1) WO2005063711A1 (enExample)
ZA (1) ZA200605658B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2449262C2 (ru) * 2007-09-28 2012-04-27 Ригаку Корпорейшн Рентгенодифракционная установка и способ рентгеновской дифракции
RU2452939C1 (ru) * 2011-01-18 2012-06-10 Закрытое акционерное общество "Научные приборы" Рентгенодифракционный способ идентификации партий фармацевтической продукции

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072040A1 (en) 2003-02-12 2004-08-26 Ciba Specialty Chemicals Holding Inc. Crystalline forms of pitavastatin calcium
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
US20120022102A1 (en) * 2010-01-20 2012-01-26 Cadila Healthcare Limited Method for preparation of pitavastatin and its pharmaceutical acceptable salts thereof
KR101158517B1 (ko) 2010-04-29 2012-06-21 동방에프티엘(주) 고 순도 피타바스타틴 칼슘염 결정형 ａ의 제조방법
JP2013536219A (ja) * 2010-08-25 2013-09-19 カディラ・ヘルスケア・リミテッド ピタバスタチンカルシウムおよびその調製方法
WO2012063254A1 (en) 2010-11-12 2012-05-18 Hetero Research Foundation Novel polymorphs of pitavastatin calcium
ITMI20111475A1 (it) * 2011-08-02 2013-02-03 Dipharma Francis Srl Forme cristalline di pitavastatina sale di calcio
WO2013037838A1 (en) 2011-09-12 2013-03-21 Farma Grs, D.O.O. Polymorphic form of pitavastatin calcium
WO2013098773A1 (en) * 2011-12-28 2013-07-04 Dr. Reddy's Laboratories Limited Crystalline forms of pitavastatin calcium
JP5190159B1 (ja) * 2012-08-08 2013-04-24 興和株式会社 医薬
CN104507949B (zh) * 2012-09-27 2017-07-28 日产化学工业株式会社 高纯度的含氮杂环化合物的制造方法
JP2014034574A (ja) * 2013-01-25 2014-02-24 Kowa Company Ltd 医薬
EP2970128B1 (en) * 2013-03-15 2019-12-04 Asieris Pharmaceutical Technologies Co., Ltd. Base addition salts of nitroxoline and uses thereof
CN105213319A (zh) * 2015-09-17 2016-01-06 青岛华之草医药科技有限公司 一种降血脂药物匹伐他汀钙组合物干混悬剂
JP2016222714A (ja) * 2016-09-20 2016-12-28 興和株式会社 医薬
TW202200547A (zh) * 2020-03-13 2022-01-01 印度商卡地拉保健有限公司 喹啉酮化合物的新穎鹽類
EP4308089A4 (en) * 2021-03-19 2025-02-26 Zydus Lifesciences Limited QUINOLONE COMPOUND IN SOLID FORMS AND PROCESSES FOR THEIR PREPARATION

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2217423C2 (ru) * 1999-01-14 2003-11-27 Ниссан Кемикал Индастриз, Лтд. Способ получения хинолинкарбальдегида

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3175944A (en) * 1956-06-18 1965-03-30 Upjohn Co Dihydronovobiocin and derivatives thereof
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
JPS61171460A (ja) * 1985-01-23 1986-08-02 Dainippon Pharmaceut Co Ltd 塩酸メクロフエノキサ−ト１型結晶の製造法
JP2569746B2 (ja) * 1987-08-20 1997-01-08 日産化学工業株式会社 キノリン系メバロノラクトン類
JP2877366B2 (ja) 1988-08-25 1999-03-31 協和醗酵工業株式会社 結晶状ｌ−アスコルビン酸−２−リン酸ナトリウム塩の製造法
JP3528186B2 (ja) * 1991-06-24 2004-05-17 日産化学工業株式会社 光学活性キノリンメバロン酸のジアステレオマー塩
JPH0613526A (ja) 1992-06-25 1994-01-21 Seiko Epson Corp 半導体装置用リードフレーム及びその製造方法
JP2575590B2 (ja) * 1992-07-31 1997-01-29 塩野義製薬株式会社 トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法
FR2694558B1 (fr) 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.
DE4235133A1 (de) 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
JP3623531B2 (ja) 1993-06-07 2005-02-23 ビーエーエスエフ アクチェンゲゼルシャフト 結晶質ｌ−アスコルビン酸−２−燐酸エステルマグネシウム塩の製造法
JP3558684B2 (ja) * 1994-06-28 2004-08-25 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の乾燥方法
CA2450820C (en) * 2001-08-16 2011-03-15 Teva Pharmaceutical Industries Ltd. Processes for preparing calcium salt forms of statins
US6835838B2 (en) 2002-01-28 2004-12-28 Novartis Ag Process for the manufacture of organic compounds
DE60326819D1 (de) * 2002-01-31 2009-05-07 Novartis Ag Verfahren zur herstellung von inhibitoren der hmg-coa-reduktase
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
US20050130978A1 (en) * 2002-04-17 2005-06-16 Masamichi Yuda Novel crystal of quinoxalinedione derivative anhydride
WO2004072040A1 (en) * 2003-02-12 2004-08-26 Ciba Specialty Chemicals Holding Inc. Crystalline forms of pitavastatin calcium
TWI328006B (en) 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2217423C2 (ru) * 1999-01-14 2003-11-27 Ниссан Кемикал Индастриз, Лтд. Способ получения хинолинкарбальдегида

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUZUKI М ЕТ AL, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol.9, no.20, 18.10.1999, pages 2977-2982 DRUGS OF THE FUTURE, vol.23, no.8, 1998, pages 847-859. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2449262C2 (ru) * 2007-09-28 2012-04-27 Ригаку Корпорейшн Рентгенодифракционная установка и способ рентгеновской дифракции
RU2452939C1 (ru) * 2011-01-18 2012-06-10 Закрытое акционерное общество "Научные приборы" Рентгенодифракционный способ идентификации партий фармацевтической продукции

Also Published As

Publication number Publication date
JP2016029102A (ja) 2016-03-03
US20210053923A1 (en) 2021-02-25
US20180072676A1 (en) 2018-03-15
KR20180132973A (ko) 2018-12-12
RU2006127044A (ru) 2008-02-10
KR20170098976A (ko) 2017-08-30
IL176470A0 (en) 2006-10-05
KR20110017936A (ko) 2011-02-22
AU2011213742C1 (en) 2017-04-06
CY1112464T1 (el) 2015-12-09
AU2011213742B2 (en) 2014-05-15
WO2005063711A1 (en) 2005-07-14
KR20180040732A (ko) 2018-04-20
JP2018052988A (ja) 2018-04-05
KR20130014643A (ko) 2013-02-07
NZ548041A (en) 2010-04-30
US20090176987A1 (en) 2009-07-09
KR20200015826A (ko) 2020-02-12
PT1697326E (pt) 2011-09-12
EP1697326A1 (en) 2006-09-06
HK1095328A1 (en) 2007-05-04
US20200216395A1 (en) 2020-07-09
US20130204000A1 (en) 2013-08-08
US20120245200A1 (en) 2012-09-27
ES2367172T3 (es) 2011-10-31
MX338019B (es) 2016-03-29
CN1898211A (zh) 2007-01-17
IL176470A (en) 2011-10-31
US20140058109A1 (en) 2014-02-27
JP2012072175A (ja) 2012-04-12
US20220177433A1 (en) 2022-06-09
CA2551050C (en) 2020-06-02
JP5186108B2 (ja) 2013-04-17
US20170226061A1 (en) 2017-08-10
US20190367458A1 (en) 2019-12-05
KR20170010111A (ko) 2017-01-25
KR20190083674A (ko) 2019-07-12
US20110082298A1 (en) 2011-04-07
US20230322679A1 (en) 2023-10-12
ZA200605658B (en) 2007-11-28
JP2013136640A (ja) 2013-07-11
JP2017061536A (ja) 2017-03-30
ATE518835T1 (de) 2011-08-15
JP2014205719A (ja) 2014-10-30
TW200530186A (en) 2005-09-16
JP2007516952A (ja) 2007-06-28
KR20070001910A (ko) 2007-01-04
DK1697326T3 (da) 2011-09-19
US20190152916A1 (en) 2019-05-23
JP5267643B2 (ja) 2013-08-21
KR20160075844A (ko) 2016-06-29
CN102321019A (zh) 2012-01-18
US20110319624A1 (en) 2011-12-29
EP1697326B1 (en) 2011-08-03
KR20200130510A (ko) 2020-11-18
US20180297956A1 (en) 2018-10-18
SI1697326T1 (sl) 2011-11-30
CN102321019B (zh) 2016-06-08
US20140206719A1 (en) 2014-07-24
PL1697326T3 (pl) 2011-12-30
AU2011213742A1 (en) 2011-09-08
US20070112024A1 (en) 2007-05-17
TWI328006B (en) 2010-08-01
AU2004309241A1 (en) 2005-07-14
CA2551050A1 (en) 2005-07-14
US20150158816A1 (en) 2015-06-11
US20240294476A1 (en) 2024-09-05

Similar Documents

Publication Publication Date Title
US20230322679A1 (en) Crystal form of quinoline compound and process for its production
AU2013204129C1 (en) Crystal Form of Quinoline Compound and Process for its Production
HK1095328B (en) Crystal form of quinoline compound and process for its production
HK1165417A (en) Crystal form of quinoline compound and process for its production

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20081126

FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20081127